Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
Authors:
Open Access
- 1 January 2012
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 3, 18886
Abstract
Non-alcoholic fatty liver disease (NAFLD) is emerging as one of the most common chronic liver diseases in developed western countries. Non-alcoholic steatohepatitis (NASH) is the most severe form of NAFLD, and can progress to more severe forms of liver disease, including fibrosis, cirrhosis, and even hepatocellular carcinoma. The activation of hepatic stellate cells plays a critical role in NASH-related fibrogenesis. Multiple factors, such as insulin resistance, oxidative stress, pro-inflammatory cytokines and adipokines, and innate immune responses, are known to contribute to the development of NASH-related fibrogenesis. Furthermore, these factors may share synergistic interactions, which could contribute to the process of liver fibrosis. Given the complex etiology of NASH, combined treatment regimes that target these different factors provide potential treatment strategies for NASH-related liver fibrosis.Keywords
This publication has 95 references indexed in Scilit:
- Liver X Receptor Signaling Is a Determinant of Stellate Cell Activation and Susceptibility to Fibrotic Liver DiseaseGastroenterology, 2011
- Intrahepatic natural killer T cell populations are increased in human hepatic steatosisWorld Journal of Gastroenterology, 2011
- Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitisJournal of Gastroenterology and Hepatology, 2009
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic SteatohepatitisGastroenterology, 2008
- The Obesity Epidemic: Pharmacological ChallengesMolecular Interventions, 2008
- A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2006
- Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Liver Fibrogenesis: A New Role for the Renin–Angiotensin SystemAntioxidants & Redox Signaling, 2005
- Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverHepatology, 2004
- Nonalcoholic SteatohepatitisSeminars in Liver Disease, 2004